“…Third, the renal cell carcinoma found in the present study had a histopathologically pleomorphic appearance. Fourth, since o-CNB was reported to be a potent mutagen with S9 activation (JETOC, 1997), possible mutagenic metabolites of o-CNB, which were presumably biotransformed from a cysteine conjugate of o-CNB metabolite, N-acetyl-S-(2-nitrophenyl)-L-cysteine (Bray et al, 1956), by β-lyase in the kidney, might act directly on the renal DNA, as suggested by Yamazaki et al (2006) who demonstrated positive nephrocarcinogenicity in male F344 rats fed 1,4-dichloro-2-nitrobenzene, a structurally similar chemical of o-CNB, for 2 years. Therefore, it can be suggested that renal cell tumors are causally related to the long-term administration of o-CNB rather than to CPN.…”